ISATUXIMAB-IRFC: 608 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
608
Total FAERS Reports
73 (12.0%)
Deaths Reported
151
Hospitalizations
608
As Primary/Secondary Suspect
38
Life-Threatening
15
Disabilities
Prescription
Status
FDA Application: 761113 ·
First Report: 20150101 · Latest Report: 20250901
What Are the Most Common ISATUXIMAB-IRFC Side Effects?
#1 Most Reported
Infusion related reaction
48 reports (7.9%)
#2 Most Reported
Dyspnoea
42 reports (6.9%)
#3 Most Reported
Off label use
35 reports (5.8%)
All ISATUXIMAB-IRFC Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Infusion related reaction | 48 | 7.9% | 1 | 10 |
| Dyspnoea | 42 | 6.9% | 3 | 13 |
| Off label use | 35 | 5.8% | 2 | 6 |
| Neutropenia | 30 | 4.9% | 7 | 17 |
| Anaemia | 23 | 3.8% | 2 | 6 |
| Disease progression | 23 | 3.8% | 16 | 4 |
| Pyrexia | 23 | 3.8% | 5 | 14 |
| Plasma cell myeloma | 22 | 3.6% | 6 | 3 |
| Thrombocytopenia | 22 | 3.6% | 2 | 2 |
| Diarrhoea | 21 | 3.5% | 0 | 10 |
| Pneumonia | 20 | 3.3% | 2 | 10 |
| Weight increased | 18 | 3.0% | 0 | 0 |
| Weight decreased | 17 | 2.8% | 1 | 1 |
| Nausea | 16 | 2.6% | 1 | 5 |
| Hypertension | 15 | 2.5% | 0 | 4 |
| Death | 14 | 2.3% | 14 | 0 |
| Acute kidney injury | 13 | 2.1% | 0 | 6 |
| Cough | 13 | 2.1% | 1 | 1 |
| Renal impairment | 12 | 2.0% | 1 | 1 |
| Vomiting | 12 | 2.0% | 1 | 6 |
Who Reports ISATUXIMAB-IRFC Side Effects? Age & Gender Data
Gender: 46.5% female, 53.5% male. Average age: 66.8 years. Most reports from: US. View detailed demographics →
Is ISATUXIMAB-IRFC Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2015 | 3 | 0 | 0 |
| 2016 | 5 | 0 | 0 |
| 2019 | 1 | 0 | 1 |
| 2020 | 20 | 1 | 3 |
| 2021 | 66 | 12 | 27 |
| 2022 | 89 | 7 | 29 |
| 2023 | 61 | 10 | 21 |
| 2024 | 58 | 5 | 24 |
| 2025 | 40 | 8 | 10 |
What Is ISATUXIMAB-IRFC Used For?
| Indication | Reports |
|---|---|
| Plasma cell myeloma | 317 |
| Product used for unknown indication | 78 |
| Plasma cell myeloma refractory | 64 |
| Plasma cell myeloma in remission | 5 |
ISATUXIMAB-IRFC vs Alternatives: Which Is Safer?
ISATUXIMAB-IRFC vs ISAVUCONAZOLE
ISATUXIMAB-IRFC vs ISAVUCONAZONIUM
ISATUXIMAB-IRFC vs ISCALIMAB
ISATUXIMAB-IRFC vs ISENTRESS
ISATUXIMAB-IRFC vs ISOFLURANE
ISATUXIMAB-IRFC vs ISONIAZID
ISATUXIMAB-IRFC vs ISONIAZID\PYRAZINAMIDE\RIFAMPIN
ISATUXIMAB-IRFC vs ISONIAZID\PYRIDOXINE\SULFAMETHOXAZOLE\TRIMETHOPRIM
ISATUXIMAB-IRFC vs ISONIAZID\RIFAMPIN
ISATUXIMAB-IRFC vs ISOPROPANOLAMINE
Official FDA Label for ISATUXIMAB-IRFC
Official prescribing information from the FDA-approved drug label.